首页 | 本学科首页   官方微博 | 高级检索  
     


Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus‐eluting stents
Authors:Eugenia Nikolsky  David R. Holmes  Roxana Mehran  George Dangas  Erick Schampaert  Marie‐Claude Morice  Joachim Schofer  J. Eduardo Sousa  Martin Fahy  Yingbo Na  Dennis J. Donohoe  Jeffrey W. Moses  Martin B. Leon
Affiliation:1. Columbia University Medical Center, Center for Interventional Vascular Therapy and the Cardiovascular Research Foundation, New York, NY, USA;2. Mayo Clinic College of Medicine, Rochester, MN, USA;3. Hopital Sacre‐Coeur de Montreal, Montreal, PQ, Canada;4. Institut Cardiovasculaire Paris Sud, Massy, France;5. Centre for Cardiology and Vascular Intervention, Hamburg, Germany;6. Institute Dante Pazzanese, S?o Paulo, Brazil;7. Cordis Corporation, Warren, NJ, USA;8. Dr. Donohoe is a full‐time employee of Johnson & Johnson. Dr. Moses owns common stock in and has served as a consultant to and speaker for Johnson & Johnson. Dr. Leon owns equity in, has received research grants from, and serves as a consultant to Johnson & Johnson.
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号